Office on Women's Health Blog
Today, the U.S. Food and Drug Administration granted an Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test BD Veritor Plus System.
The U.S. Surgeon General and the U.S. Department of Health and Human Services today released a public service announcement (PSA) ahead of the Fourth of July weekend imploring Americans to take action and to remember: COVID Stops With Me.
The HHS Office for Human Research Protections (OHRP) issued guidance on COVID-19 for investigators, institutional review boards, and institutions conducting human subjects research during the coronavirus (COVID-19) pandemic.
Earlier today, the Office of the Assistant Secretary for Health issued new guidance under the Public Readiness and Emergency Preparedness Act authorizing licensed pharmacists to order and administer COVID-19 tests that the U.S. Food and Drug Administration has authorized.
The U.S. Department of Health and Human Services is purchasing the ID NOW COVID-19 rapid point-of-care test, developed by Abbott Diagnostics Scarborough Inc., for state, territorial and tribal public health labs.
Because of the unprecedented demand on hospital and ICU resources during the COVID-19 (SARS CoV-2) pandemic, many hospitals may be challenged with providing mechanical ventilation to all those in need of this therapy.
A team of specialized officers from the U.S. Public Health Service (USPHS) Commissioned Corps are working with the United States Embassy in Japan, the Japanese Ministry of Health, Labour and Welfare, and Gilead Sciences Inc.
Gabrielle Davis found out she had lupus in 2009. She says her diagnosis turned her world upside down, and it took her a few years to feel like her pre-lupus self. Gabrielle talks about her diagnosis, how it changed the way she thinks about herself, and what she wants others to know about the disease.